Support patients and their caregivers with home-based services that initiate complex therapies faster, improve adherence and persistence, and foster a more satisfying experience. Our nationwide network of nearly 9,000 credentialed clinicians makes it easier for patients to receive vital treatments, so they can enjoy more healthy, happy days at home.
We work with a wide range of biopharmaceutical companies and partners, supporting clinical trials and commercialization.
Whether a drug is in late-stage clinical development or already FDA-approved, Signify Health offers coordinated, community-based clinical services and support during the patient's journey, helping to drive better outcomes.
Maximize patient access to innovative therapies, critical to maintain — and grow — market share. Whether performing lab tests, administering complex dosing regimens, or connecting patients to food, housing, and other social services, we help support patients throughout the entire treatment journey.
Ensure clinical consistency and accurate data capture via our integrated technology platform, which draws on our experience conducting more than one million in-home health evaluations in the past year via our nationwide network of contracted clinicians (not agency-based).
Proprietary clinician and supply logistics software enables nationwide support for patients.
Intelligent evaluation and documentation platform capture a holistic picture of each patient’s health and transmits it to healthcare providers.
Multi-visit coordination, patient contraindication risk reviews, and additional device integrations can be included to support specific needs.
The Children’s Oncology Group, the world's largest organization devoted exclusively to childhood and adolescent cancer research, and Signify Health are partnering to facilitate clinical trial participation for pediatric patients through in-home clinical services. See what our collaboration means for AALL1731 B-ALL studies in this Outsourcing Pharma interview.
Signify led a panel discussion at South by Southwest (SXSW) 2021 on clinical trial diversity alongside Pfizer’s Head of Clinical Trial Diversity Sandra Amaro and Parexel Chief Commercial & Strategy Officer Peyton Howell. See how these leading changemakers are advancing racial equity in clinical trials — starting with lessons learned from COVID-19.